TrialAnnals of oncology : official journal of the European Society for Medical Oncology2018

Clinical consequences of upfront pathology review in the randomised PORTEC-3 trial for high-risk endometrial cancer.

S M de Boer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.